Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02851641

Acronym

CANALHEMO

Enrollment

108

Registered

2016-08-01

Start date

2015-09-02

Completion date

2019-12-10

Last updated

2019-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lacrimal Duct Obstruction

Brief summary

The aim of the study is to evaluate the risk in intra-operative nasal hemorrhage when using a pushed probe (Master Ka) in the treatment of naso lacrimal duct obstruction (NLDO). In the investigator's experience, this risk seemed to minus using a pushed probe rather than the classical pulled-type probes. A lower risk of hemorrhage could lead to a change in the anesthetic procedure. The gold standard in NLDO is the use of an orotracheal intubation. It could then be replaced by the use of an orolaryngeal mask. A forthcoming study will evaluate the results of this anesthetic change.

Interventions

PROCEDUREpushed mono-canaliculonasal intubation

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 6 Years

Healthy volunteers

Inclusion criteria

* \< 6 years of age * Unilateral lacrimal duct obstruction with programmed surgery * Surgery scheduled wih a pushed mono-canaliculonasal intubation * No opposition of parents for he participation of their child

Exclusion criteria

* Coagulation disorder * Previous history of nasolacrimal intubation (homo or contra-lateral) * Non covered by health insurance

Design outcomes

Primary

Measure	Time frame
Nasal hemorrhage	Through surgery completion, an average of 1 hour

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026